Polycythemia Vera Clinical Trial


Study Information

Study Title

Prospective, Non-Interventional Study of Disease Progression and Treatment of Patients with Polycythemia Vera in United States Academic or Community Clinical Practices (REVEAL)

Study Summary

This is a Phase IV, multicenter, non-interventional, non-randomized, prospective, observational study in an adult population (patients >18 years old) of men and women who have been diagnosed with clinically overt PV and are being followed in either community or academic medical centers in the United States who will be enrolled over a 12-month period and observed for 36 months from the date the last patient is enrolled.

Principal Investigator

Myron Bednar, MD

Phase IV

If you have any questions regarding this study or think that you or your loved one may be eligible, please contact our Clinical Trial Coordinator by dialing 908.237.2330 extension 2.

Contact HHO

All questions and feedback are welcome, anytime.






    About HHO


    Hunterdon Hematology Oncology is a community oncology group, dedicated to fighting cancer in this community and across the region. Our Doctors, Physician’s Assistants and Nurses work tirelessly. They fight hard so that you can win.




    Subscribe


    Sign up for the HHO newsletter to stay up to date on the latest news within the practice and the community.



      © HHO 2022. All rights reserved. Designed by DRAW